These maps are valuable tools used by stakeholders in the pharmaceutical industry to analyze and optimize the process of patient engagement, treatment, and care.

Artificial intelligence (AI) enabled tools are changing the game for healthcare providers, researchers, and patients alike.

To reap the most value for patients as well as their key stakeholders, pharmaceutical companies need to focus on building and maintaining strong relationships between their MSLs and KOLs in their therapeutic areas.

There are many ways to identify your key customer segments and get insights from them. While we’ve used lots of different survey tools for this purpose, one of the newer methods we’ve been using is social listening.

Key opinion leader (KOL) profiling is a structured process used to identify and analyze influential individuals who make up the contingent of health care professionals who push medical science forward in a given disease area. The methodology for KOL profiling involves several key components.

Life sciences companies are working with and monitoring the online activities of digital opinion leaders (DOLs), as they exchange scientific data with their colleagues online and shape disease state opinions on effective treatments.

Here are some key aspects of the pharmaceutical industry's role in patient engagement.

In the ever-evolving landscape of the pharmaceutical industry, staying attuned to the opinions and perspectives of key opinion leaders KOLs) has emerged as a critical imperative.

In a healthcare landscape where science is rapidly evolving, medical education is more important than ever.

In the dynamic realm of pharmaceuticals, the intricate interplay between global strategies and regional, cultural nuances presents a tightrope walk for medical affairs leaders.

Developing tailored engagement strategies based on KOL preferences can amplify the impact of medical affairs efforts, fostering partnerships that contribute to successful product launches and continued growth.

The journey to optimal health in modern medicine doesn't end with a prescription. The journey begins with the powerful skill of adherence.

Voice of Customer research can help strengthen the bond between pharma companies and Key Opinion Leaders (KOLs) – creating meaningful partnerships that drive scientific advancements, improved patient outcomes, and mutual growth.

Pharmaceutical companies seeking to truly understand patient experiences in a disease area benefit from patient journey maps, which provide valuable insight into a patient's needs, emotions, and pain points at each stage of their healthcare journey.

Thought Leader Select has announced another leadership appointment, as Mark Schoeman has been named General Manager of the company’s Clear Point Health division.

After closing out a prolific 2022, CPH is proud to announce a trio of colleagues taking on leadership roles with the company’s research team.

By Paul Meade, Patient Engagement Lead For many decades, the healthcare thought Leader, also known as a key opinion leader (KOL), or key external expert

By Mark Schoeman, General Manager Prior to and over the course of the pandemic, assessments have shown that scores for MSL teams have remained consistent.

Finally, for all the right reasons, the US healthcare system sees the need to focus more on patient outcomes and tie payment to the level of healthcare “value” delivered.

In 2022, there are hundreds of thousands of healthcare companies in the United States alone.